Clinical Trial Update: Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants [Phase 2]

View source ↗

Summary

Phase 2 trial update for a malaria vaccine candidate in Tanzanian infants assessing safety, immunogenicity, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Malaria Vaccines | Phase 2 | Status: COMPLETED | Results posted: 2013-07-08